Junshi Biosciences Announces Acceptance of the Supplemental NDA for Toripalimab in Combination with Chemotherapy for Advanced Triple-negative Breast Cancer

SHANGHAI, China, May 23, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (“NMPA”) has accepted the supplemental new drug application (“sNDA”) for the company’s anti-PD-1 monoclonal […]

Continue Reading

ZEE5 Moves to ScyllaDB NoSQL to Enhance User Experience at Scale with Predictable Costs

ScyllaDB is fast becoming the go-to database for global media streaming leaders as well as India’s top gamechangers BANGALORE, India and SUNNYVALE, Calif., May 22, 2023 (GLOBE NEWSWIRE) — ScyllaDB announced today that ZEE5 is now using its high-performance database for its rapidly growing streaming business. By moving from DynamoDB to ScyllaDB Cloud (a fully […]

Continue Reading